Literature DB >> 17158849

Smoking during pregnancy: where next for stage-based interventions?

Wendy T Lawrence1, Cheryl Haslam.   

Abstract

Pregnancy is a 'window of opportunity' for encouraging positive behaviour change, such as quitting smoking. Associations have been shown between smoking stage of change and other health behaviour during pregnancy. For example, women in the precontemplative stage have poorer assessment of risks associated with smoking, feel less personally responsible for their unborn child's health and in turn are less likely to adopt health-promoting behaviour. Stage of change models are a popular tool within the health services, but the results of stage-based smoking cessation interventions are mixed. Identifying the crucial components of effective interventions is an important imperative for research in this area. This article reviews the literature to ascertain these components and makes recommendations for designing effective interventions.

Entities:  

Mesh:

Year:  2007        PMID: 17158849     DOI: 10.1177/1359105307071750

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  3 in total

1.  Knowledge and attitudes of adults towards smoking in pregnancy: results from the HealthStyles© 2008 survey.

Authors:  Kara N D Polen; Paramjit K Sandhu; Margaret A Honein; Katie K Green; Judy M Berkowitz; Jill Pace; Sonja A Rasmussen
Journal:  Matern Child Health J       Date:  2015-01

2.  Exposure to active and passive smoking among Greek pregnant women.

Authors:  Victoria G Vivilaki; Athina Diamanti; Maria Tzeli; Evridiki Patelarou; Debra Bick; Sophia Papadakis; Katerina Lykeridou; Paraskevi Katsaounou
Journal:  Tob Induc Dis       Date:  2016-04-05       Impact factor: 2.600

3.  What helped and hindered implementation of an intervention package to reduce smoking in pregnancy: process evaluation guided by normalization process theory.

Authors:  Susan Jones; Sharon Hamilton; Ruth Bell; Vera Araújo-Soares; Svetlana V Glinianaia; Eugene M G Milne; Martin White; Martyn Willmore; Janet Shucksmith
Journal:  BMC Health Serv Res       Date:  2019-05-09       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.